Effects of nemonapride on positive and negative symptoms of schizophrenia

International Clinical Psychopharmacology

Volumn 11, Issue 4, 1996, Pages 279-281

  Satoh, K ^a   Someya, T ^a   Shibasaki, M ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; EMONAPRIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030452296     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199612000-00010     Document Type: Article

References (12)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. APA, Washington, DC.
2. Baldessarini RJ and Frankenburg FR (1991) Clozapine. A novel antipsychotic agent. New England Journal of Medicine, 324, 746-754.
3. Kane J, Honigfeld G, Singer J, Meltzer H et al. (1988) Clozapine for treatment-resistant schizophrenia. Archives of General Psychiatry, 45, 789-796.
4. Koshiya K, Morita T and Usuda S (1992) Behavioral suppressive and disinhibitory effects of nemonapride: possible biological basis of its antipsychotic efficacies. Clinical Neuropharmacology, 15 (suppl 1), 453B.
5. Lewander T, Westerbergh S-E and Morrison D (1990) Clinical profile of remoxipride - a combined analysis of a comparative double-blind multicentre trial programme. Acta Psychiatrica Scandinavica, 82 (Suppl 358), 92-98.
6. Mori O, Kazamatsuri H, Kaneno S et al. (1989) A double-blind comparison of a new benzamide compound of YM-09151 with haloperidol in the treatment of schizophrenia. Clinical Evaluation, 17, 349-377 (in Japanese, with English abstract).
7. Nishio T, Narita M and Satoh K (1993) Immunocytochemical study on the effect of neuroleptics on proto-oncogene c-fos expression in the rat forebrain: comparison of nemonapride and haloperidol. Japanese Journal of Neuropsychopharmacology, 15, 391-399 (in Japanese, with English abstract).
8. Seeman P, Guan H-H and Van Tol HHM. (1993) Dopamine D4 receptors elevated in schizophrenia. Nature, 365, 441-445.
9. Sokoloff P., Giros B, Martres M-P et al. (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature, 347, 146-151.
10. 3H]raclopride for dopamine D-2 receptor binding to rat striatum. European Journal of Pharmacology, 173, 177-182.
11. Van Tol HHM, Bunzow JR, Guan HC et al. (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature, 350, 610-614.
12. Yamamoto M, Usuda S, Tachikawa S and Maeno H (1982) Pharmacological studies on a new benzamide derivative, YM-09151-2 with potential neuroleptic properties. Neuropharmacology, 21, 945-951.